This site is intended for health professionals only
Thursday 27 June 2019
Share |

Topic: avastin

November 10, 2017
ABP 215 is being developed as a biosimilar to bevacizumab

Amgen and Allergan have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing Authorisation of ABP 215, a biosimilar to Avastin® (bevacizumab).

 

May 10, 2016
Victory for Scots as targeted treatment Avastin® (bevacizumab) can become a new standard of care

April 27, 2015
The European Commission has licenced Avastin in combination with standard chemotherapy for the treatment of women with advanced cervical cancer. Until now, the treatment has been available ahead of licence to eligible patients in England via individual requests to the Cancer Drugs Fund (CDF).

The European Commission has licenced Avastin in combination with standard chemotherapy for the treatment of women with advanced cervical cancer. Until now, the treatment has been available ahead of licence to eligible patients in England via individual requests to the Cancer Drugs Fund (CDF).

June 16, 2014
Dr Steven Bradshaw, a drug policy expert and former ophthalmologist, is disappointed at the news of the Italian government’s decision to substitute wet age-related macular degeneration treatment drug, from Lucentis to Roche’s Avastin.

Dr Steven Bradshaw, a drug policy expert and former ophthalmologist, is disappointed at the news of the Italian government’s decision to change the wet age-related macular degeneration (AMD) treatment drug, from Lucentis to Roche’s Avastin.

October 12, 2010
A study has revealed that a drug used to treat bowel, breast and lung cancer could help prolong the lives of women suffering from ovarian cancer

teaser

July 21, 2010
The Swiss drug might be soon withdrawn from the US market due to its lack of benefits and high risks of intoxication when used alongside chemotherapy

teaser

September 23, 2009
From inoperable disease to potentially life saving surgery - new Avastin data gives hope to colorectal cancer patients with liver metastases

teaser

April 22, 2009
Phase III C-08 study of Avastin in early-stage colon cancer does not meet primaryendpoint

teaser

April 1, 2009
Successful studies of cancer drug warrant accelerated approval

teaser

March 30, 2009
Fears that the cancer drug Avastin may not perform as well as makers Genentech has advertised have been voiced by the US FDA

teaser

March 9, 2009
Roche has raised its hostile bid offer for Genentech to $93 (

teaser

February 4, 2009
Avastin and Tarceva in combination significantly improves the time patients with advanced lung cancer can live without their disease worsening

teaser

January 23, 2009
Cancer patients in Wales, UK, have been granted greater access to life-prolonging treatment

teaser

December 1, 2008
Banned kidney cancer drugs could benefit half of those suffering from the disease

teaser

November 20, 2008
Cancer drug linked to increased risk of deep-vein blood clots, or venous thromboembolism

teaser

November 10, 2008
Wonder drug deemed too expensive for NHS is defended by manufacturer

teaser

October 16, 2008
Survey of oncologists says Avastin is the most promising early-stage colorectal cancer drug

teaser

August 28, 2008
Protests erupt in London after treatment for kidney cancer on the NHS is rejected

teaser

January 30, 2008
The EC has approved bevacizumab in combination with standard chemotherapy for advanced bowel cancer

teaser

January 16, 2008
Biotechnology firm Genentech has only just met Wall Street expectations as the firm renowned for its phenomenal growth posted a 6% rise in fourth-quarter profits.

teaser

December 19, 2007
Roche's product has gained another green light in Europe, this time for treating patients with advanced kidney cancer

teaser

December 7, 2007
A panel of US Government advisers has ruled that Avastin (bevacizumab) should not be approved for extended use in breast cancer patients.

teaser

December 5, 2007
The Food and Drug Administration (FDA) is to consult outside experts on whether Avastin (bevacizumab) should be approved to treat breast cancer in the US.

teaser

November 20, 2007
The Committee for Medicinal Products for Human Use of the EMEA has recommended the adoption of a new indication for bevacizumab

teaser

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine